BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 35658529)

  • 21. Functional and Highly Cross-Linkable HIV-1 Envelope Glycoproteins Enriched in a Pretriggered Conformation.
    Nguyen HT; Qualizza A; Anang S; Zhao M; Zou S; Zhou R; Wang Q; Zhang S; Deshpande A; Ding H; Chiu TJ; Smith AB; Kappes JC; Sodroski JG
    J Virol; 2022 Apr; 96(8):e0166821. PubMed ID: 35343783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of neutralization specificities in polyclonal sera derived from human immunodeficiency virus type 1-infected individuals.
    Li Y; Svehla K; Louder MK; Wycuff D; Phogat S; Tang M; Migueles SA; Wu X; Phogat A; Shaw GM; Connors M; Hoxie J; Mascola JR; Wyatt R
    J Virol; 2009 Jan; 83(2):1045-59. PubMed ID: 19004942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Envelope deglycosylation enhances antigenicity of HIV-1 gp41 epitopes for both broad neutralizing antibodies and their unmutated ancestor antibodies.
    Ma BJ; Alam SM; Go EP; Lu X; Desaire H; Tomaras GD; Bowman C; Sutherland LL; Scearce RM; Santra S; Letvin NL; Kepler TB; Liao HX; Haynes BF
    PLoS Pathog; 2011 Sep; 7(9):e1002200. PubMed ID: 21909262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies.
    Gnanakaran S; Daniels MG; Bhattacharya T; Lapedes AS; Sethi A; Li M; Tang H; Greene K; Gao H; Haynes BF; Cohen MS; Shaw GM; Seaman MS; Kumar A; Gao F; Montefiori DC; Korber B
    PLoS Comput Biol; 2010 Oct; 6(10):e1000955. PubMed ID: 20949103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural characterization of cleaved, soluble HIV-1 envelope glycoprotein trimers.
    Khayat R; Lee JH; Julien JP; Cupo A; Klasse PJ; Sanders RW; Moore JP; Wilson IA; Ward AB
    J Virol; 2013 Sep; 87(17):9865-72. PubMed ID: 23824817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-V3/Glycan and Anti-MPER Neutralizing Antibodies, but Not Anti-V2/Glycan Site Antibodies, Are Strongly Associated with Greater Anti-HIV-1 Neutralization Breadth and Potency.
    Jacob RA; Moyo T; Schomaker M; Abrahams F; Grau Pujol B; Dorfman JR
    J Virol; 2015 May; 89(10):5264-75. PubMed ID: 25673728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nef decreases HIV-1 sensitivity to neutralizing antibodies that target the membrane-proximal external region of TMgp41.
    Lai RP; Yan J; Heeney J; McClure MO; Göttlinger H; Luban J; Pizzato M
    PLoS Pathog; 2011 Dec; 7(12):e1002442. PubMed ID: 22194689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-human immunodeficiency virus type 1 (HIV-1) antibodies 2F5 and 4E10 require surprisingly few crucial residues in the membrane-proximal external region of glycoprotein gp41 to neutralize HIV-1.
    Zwick MB; Jensen R; Church S; Wang M; Stiegler G; Kunert R; Katinger H; Burton DR
    J Virol; 2005 Jan; 79(2):1252-61. PubMed ID: 15613352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antigenic properties of the human immunodeficiency virus transmembrane glycoprotein during cell-cell fusion.
    Finnegan CM; Berg W; Lewis GK; DeVico AL
    J Virol; 2002 Dec; 76(23):12123-34. PubMed ID: 12414953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Asymmetric Structures and Conformational Plasticity of the Uncleaved Full-Length Human Immunodeficiency Virus Envelope Glycoprotein Trimer.
    Zhang S; Wang K; Wang WL; Nguyen HT; Chen S; Lu M; Go EP; Ding H; Steinbock RT; Desaire H; Kappes JC; Sodroski J; Mao Y
    J Virol; 2021 Nov; 95(24):e0052921. PubMed ID: 34549974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antigenic characterization of the human immunodeficiency virus (HIV-1) envelope glycoprotein precursor incorporated into nanodiscs.
    Witt KC; Castillo-Menendez L; Ding H; Espy N; Zhang S; Kappes JC; Sodroski J
    PLoS One; 2017; 12(2):e0170672. PubMed ID: 28151945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disruption of helix-capping residues 671 and 674 reveals a role in HIV-1 entry for a specialized hinge segment of the membrane proximal external region of gp41.
    Sun ZY; Cheng Y; Kim M; Song L; Choi J; Kudahl UJ; Brusic V; Chowdhury B; Yu L; Seaman MS; Bellot G; Shih WM; Wagner G; Reinherz EL
    J Mol Biol; 2014 Mar; 426(5):1095-108. PubMed ID: 24075869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neutralization efficiency is greatly enhanced by bivalent binding of an antibody to epitopes in the V4 region and the membrane-proximal external region within one trimer of human immunodeficiency virus type 1 glycoproteins.
    Wang P; Yang X
    J Virol; 2010 Jul; 84(14):7114-23. PubMed ID: 20463081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gp41-targeted antibodies restore infectivity of a fusion-deficient HIV-1 envelope glycoprotein.
    Joshi VR; Newman RM; Pack ML; Power KA; Munro JB; Okawa K; Madani N; Sodroski JG; Schmidt AG; Allen TM
    PLoS Pathog; 2020 May; 16(5):e1008577. PubMed ID: 32392227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogens Modeling a Fusion-Intermediate Conformation of gp41 Elicit Antibodies to the Membrane Proximal External Region of the HIV Envelope Glycoprotein.
    Vassell R; He Y; Vennakalanti P; Dey AK; Zhuang M; Wang W; Sun Y; Biron-Sorek Z; Srivastava IK; LaBranche CC; Montefiori DC; Barnett SW; Weiss CD
    PLoS One; 2015; 10(6):e0128562. PubMed ID: 26087072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct antibody access to the HIV-1 membrane-proximal external region positively correlates with neutralization sensitivity.
    Chakrabarti BK; Walker LM; Guenaga JF; Ghobbeh A; Poignard P; Burton DR; Wyatt RT
    J Virol; 2011 Aug; 85(16):8217-26. PubMed ID: 21653673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Membrane Env Liposomes Facilitate Immunization with Multivalent Full-Length HIV Spikes.
    Leaman DP; Stano A; Chen Y; Zhang L; Zwick MB
    J Virol; 2021 Jun; 95(13):e0000521. PubMed ID: 33883221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of a Tier-1-Like Phenotype in Diverse Tier-2 Isolates by Agents That Guide HIV-1 Env to Perturbation-Sensitive, Nonnative States.
    Johnson J; Zhai Y; Salimi H; Espy N; Eichelberger N; DeLeon O; O'Malley Y; Courter J; Smith AB; Madani N; Sodroski J; Haim H
    J Virol; 2017 Aug; 91(15):. PubMed ID: 28490588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maturation-induced cloaking of neutralization epitopes on HIV-1 particles.
    Joyner AS; Willis JR; Crowe JE; Aiken C
    PLoS Pathog; 2011 Sep; 7(9):e1002234. PubMed ID: 21931551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cholesterol-dependent membrane fusion induced by the gp41 membrane-proximal external region-transmembrane domain connection suggests a mechanism for broad HIV-1 neutralization.
    Apellániz B; Rujas E; Carravilla P; Requejo-Isidro J; Huarte N; Domene C; Nieva JL
    J Virol; 2014 Nov; 88(22):13367-77. PubMed ID: 25210180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.